drug

ibrexafungerp

1 story · latest Aug 10, 2026

Status: FDA approved Jun 2021 · NDA214900
Brand: Brexafemme
Code: SCY-078
Trials: 1 registered trial in coverage

Relationships

Developed by GlaxoSmithKline

Also known as

ibrexafungerp citrate

Timeline

Scynexis posts results for terminated Phase 3 MARIO trial in invasive candidiasis

Aug 10Trial updateechinocandin Scynexis Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.